Biogen Inc. (BIIB) Up 1.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/19/22
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could HelpInvestors Business Daily • 08/11/22
EISAI PRESENTS NEW FINDINGS ON LECANEMAB'S INVESTIGATIONAL SUBCUTANEOUS FORMULATION AND MODELING SIMULATION OF APOE4 GENOTYPE ON ARIA-E INCIDENCE AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) 2022PRNewsWire • 08/03/22
These eight health-care stocks can keep you invested in the market with less worryMarket Watch • 08/02/22
The New England Journal of Medicine Publishes Positive Phase 2 Data on Litifilimab (BIIB059) in Cutaneous Lupus ErythematosusGlobeNewsWire • 07/28/22
FDA Accepts Biogen's New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALSGlobeNewsWire • 07/26/22
Biogen Inc. (BIIB) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/25/22
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/20/22